Authors: Levesque, MA Katsaros, D Massobrio, M Genta, F Yu, H Richiardi, G Fracchioli, S Durando, A Arisio, R Diamandis, EP

Citation: Ma. Levesque et al., Evidence for a dose-response effect between p53 (but not p21(WAF1/Cip1)) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy, CLIN CANC R, 6(8), 2000, pp. 3260-3270

Authors: Casalegno, PS Sandrucci, S Bello, M Durando, A Danese, S Silvestro, L Pellerito, R Testori, O Roagna, R Giai, M Giani, R Bussone, R Favero, A Bisi, G Massobrio, M Giardina, G Mussa, GC Sismondi, P Mussa, A

Citation: Ps. Casalegno et al., Sentinel lymph node and breast cancer staging: Final results of the Turin multicenter study, TUMORI, 86(4), 2000, pp. 300-303

Authors: Bellino, R Cortese, P Danese, S De Sanctis, C Durando, A Genta, F Grio, R Giardina, G Katsaros, D Massobrio, M Richiardi, G Vicelli, R

Citation: R. Bellino et al., Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3cm and T4 breast cancer patients, ANTICANC R, 20(6C), 2000, pp. 4825-4828

Authors: Lianidous, ES Angelopoulou, K Katsaros, D Durando, A Massobrio, M Diamandis, EP

Citation: Es. Lianidous et al., Fragment analysis of the p53 gene in ovarian tumors (vol 31, pg 551, 1998), CLIN BIOCH, 32(2), 1999, pp. 155-155

Authors: Katsaros, D Levesque, MA Genta, F Durando, A Bellino, R Richiardi, G Fracchioli, S Diamandis, EP Massobrio, M

Citation: D. Katsaros et al., Dose-response effect between p53 concentrations, survival and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 225-229